MedImmune Licenses BioWa’s POTELLIGENT™ Technology
News Dec 07, 2005
BioWa, Inc. has announced that MedImmune, Inc. has licensed BioWa's POTELLIGENT™ technology for use in researching and developing select MedImmune antibodies for potential therapeutic applications that require enhancement of antibody-dependent cellular cytotoxicity (ADCC).
"We are delighted that MedImmune, a recognized biotechnology leader, has decided to use our POTELLIGENT™ technology as a method for maximizing the potential of therapeutic antibodies," said Dr. Nobuo Hanai, BioWa President and CEO.
"We believe that this collaboration with MedImmune highlights the potential advantages of our ADCC-enhancing technology and furthers BioWa's goal to bring about safe and more effective treatments for cancer and other life-threatening and debilitating diseases."
Under the terms of the agreement, BioWa will provide MedImmune with non- exclusive commercial rights to use the technology to enhance ADCC in developing antibodies for multiple targets.
In return, BioWa will receive technology access fees, and may receive milestone payments and royalties on products developed by MedImmune.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE